Table 1.
Trimester | Subjects, n | IgM+/IgG+ | IgM−/IgG+ |
---|---|---|---|
1st | 270 | 17 (6.3%) | 253 (93.7%) |
2nd | 66 | 6 (9.1%)a | 60 (90.9%) |
3rd | 210 | 17 (8.1%)a | 193 (91.9%) |
Total | 546 | 40 (7.3%) | 506 (92.7%) |
Twenty-three women in the second and third trimester who were positive for CMV IgM and IgG had their first-trimester blood retrieved and tested by CMV IgG avidity.